Bumetanide
Product Images NDC 68151-1744

2 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 68151-1744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4b10a074 Daac 4448 9dbe B65c549e5c59 01)

Chemical Structure (4b10a074 Daac 4448 9dbe B65c549e5c59 01)
Chemical structure of the active ingredient in Bumetanide, showing its molecular composition including functional groups such as carboxyl, sulfonamide, and aromatic rings, as depicted in the image.*
FDA Label Image

Label Image (68151 1744)

Label Image (68151 1744)
Bumetanide 1 mg tablet packaging label showing the drug name, dosage strength, form, and manufacturer Sandoz. The label includes manufacturing and expiration dates, a dosage instruction indicating use by mouth once daily, and the product NDC 68151-1744.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.